Binfeng Xia

649 total citations
19 papers, 470 citations indexed

About

Binfeng Xia is a scholar working on Pharmaceutical Science, Pharmacology and Oncology. According to data from OpenAlex, Binfeng Xia has authored 19 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 6 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Binfeng Xia's work include Drug Solubulity and Delivery Systems (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Advanced Drug Delivery Systems (6 papers). Binfeng Xia is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Advanced Drug Delivery Systems (6 papers). Binfeng Xia collaborates with scholars based in United States, Switzerland and Belgium. Binfeng Xia's co-authors include Tycho Heimbach, Handan He, Tsu‐Han Lin, Filippos Kesisoglou, Neil Parrott, Nancy Agrawal, Christophe Tistaert, Tanay S. Samant, Yanfeng Wang and Jennifer Sheng and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Clinical Pharmacology & Therapeutics and Powder Technology.

In The Last Decade

Binfeng Xia

19 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Binfeng Xia United States 12 189 123 112 96 82 19 470
Patrick Marroum United States 17 295 1.6× 147 1.2× 82 0.7× 125 1.3× 76 0.9× 36 777
Donato Teutonico France 12 99 0.5× 185 1.5× 111 1.0× 125 1.3× 41 0.5× 22 674
Nikunjkumar Patel United Kingdom 19 373 2.0× 98 0.8× 99 0.9× 193 2.0× 113 1.4× 36 795
Jan Welink Netherlands 11 141 0.7× 39 0.3× 157 1.4× 76 0.8× 41 0.5× 25 459
Arian Emami Riedmaier United States 10 106 0.6× 152 1.2× 287 2.6× 212 2.2× 44 0.5× 12 601
Paul Seo United States 16 347 1.8× 84 0.7× 115 1.0× 204 2.1× 100 1.2× 24 779
Noriko Katori Japan 14 225 1.2× 198 1.6× 175 1.6× 131 1.4× 41 0.5× 35 652
Sandra Suarez‐Sharp United States 11 337 1.8× 43 0.3× 57 0.5× 139 1.4× 71 0.9× 22 505
Shriram M. Pathak India 11 219 1.2× 55 0.4× 87 0.8× 78 0.8× 66 0.8× 20 394
Manuela Grimstein United States 9 51 0.3× 244 2.0× 145 1.3× 93 1.0× 40 0.5× 14 535

Countries citing papers authored by Binfeng Xia

Since Specialization
Citations

This map shows the geographic impact of Binfeng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binfeng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binfeng Xia more than expected).

Fields of papers citing papers by Binfeng Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binfeng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binfeng Xia. The network helps show where Binfeng Xia may publish in the future.

Co-authorship network of co-authors of Binfeng Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Binfeng Xia. A scholar is included among the top collaborators of Binfeng Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binfeng Xia. Binfeng Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cohen, Yehuda Z., Xiaojia Zhang, Binfeng Xia, et al.. (2022). Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe. Clinical Pharmacology in Drug Development. 11(5). 675–681. 8 indexed citations
2.
3.
Heimbach, Tycho, Yuan Chen, Jun Chen, et al.. (2020). Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective. Clinical Pharmacology & Therapeutics. 110(2). 297–310. 91 indexed citations
4.
Xia, Binfeng, et al.. (2020). Effect of TPGS surfactant on dissolution sensitivity of a poorly water-soluble drug using high-shear wet granulation. Powder Technology. 375. 302–309. 9 indexed citations
5.
Patel, Sanjaykumar R., Wei Zhu, Binfeng Xia, et al.. (2018). Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs. Journal of Pharmaceutical Sciences. 108(1). 574–583. 21 indexed citations
6.
Tistaert, Christophe, Tycho Heimbach, Binfeng Xia, et al.. (2018). Food Effect Projections via Physiologically Based Pharmacokinetic Modeling: Predictive Case Studies. Journal of Pharmaceutical Sciences. 108(1). 592–602. 57 indexed citations
7.
Kesisoglou, Filippos, Binfeng Xia, & Nancy Agrawal. (2015). Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate. The AAPS Journal. 17(6). 1492–1500. 36 indexed citations
8.
Xia, Binfeng, Haiying Zhou, Viera Lukáčová, et al.. (2015). Development of a Novel Oral Cavity Compartmental Absorption and Transit Model for Sublingual Administration: Illustration with Zolpidem. The AAPS Journal. 17(3). 631–642. 21 indexed citations
9.
Walsh, Paul L., Jameson R. Bothe, Sunny P. Bhardwaj, et al.. (2015). A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets. Drug Development and Industrial Pharmacy. 42(5). 836–844. 3 indexed citations
10.
Zhang, Hefei, Binfeng Xia, Jennifer Sheng, et al.. (2014). Application of Physiologically Based Absorption Modeling to Formulation Development of a Low Solubility, Low Permeability Weak Base: Mechanistic Investigation of Food Effect. AAPS PharmSciTech. 15(2). 400–406. 29 indexed citations
11.
Xia, Binfeng, Avantika Barve, Tycho Heimbach, et al.. (2014). Physiologically based pharmacokinetic modeling for assessing the clinical drug–drug interaction of alisporivir. European Journal of Pharmaceutical Sciences. 63. 103–112. 11 indexed citations
12.
13.
Xia, Binfeng, Tycho Heimbach, Tsu‐Han Lin, et al.. (2013). Utility of Physiologically Based Modeling and Preclinical In Vitro/In Vivo Data to Mitigate Positive Food Effect in a BCS Class 2 Compound. AAPS PharmSciTech. 14(3). 1255–1266. 20 indexed citations
14.
Heimbach, Tycho, Binfeng Xia, Tsu‐Han Lin, & Handan He. (2012). Case Studies for Practical Food Effect Assessments across BCS/BDDCS Class Compounds using In Silico, In Vitro, and Preclinical In Vivo Data. The AAPS Journal. 15(1). 143–158. 46 indexed citations
15.
Xia, Binfeng, Tycho Heimbach, Tsu‐Han Lin, et al.. (2012). Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions. Cancer Chemotherapy and Pharmacology. 69(6). 1567–1582. 21 indexed citations
16.
Xia, Binfeng, Tycho Heimbach, Handan He, & Tsu‐Han Lin. (2012). Nilotinib preclinical pharmacokinetics and practical application toward clinical projections of oral absorption and systemic availability. Biopharmaceutics & Drug Disposition. 33(9). 536–549. 33 indexed citations
17.
Wong, Harvey, Binfeng Xia, & Vincent Tong. (2012). Atypical Kinetics of Valproic Acid Glucuronidation In vitro and In vivo in Humans. Pharmaceutica Analytica Acta. 1(S1). 6 indexed citations
18.
Xia, Binfeng, et al.. (2010). Preclinical pharmacokinetics and metabolism of MNP001, a piperidine analog of 3‐carbamyl compounds. Biopharmaceutics & Drug Disposition. 32(1). 25–37. 2 indexed citations
19.
Xia, Binfeng, et al.. (2009). HPLC/MS/MS analysis of 3-carbamyl-4-methylpyrrole analog MNP001, a highly potent antihypertensive agent, in rat plasma. Journal of Chromatography B. 877(20-21). 1867–1872. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Marroum Breakdown of academic impact, for papers by Donato Teutonico Breakdown of academic impact, for papers by Nikunjkumar Patel Breakdown of academic impact, for papers by Jan Welink Breakdown of academic impact, for papers by Arian Emami Riedmaier Breakdown of academic impact, for papers by Paul Seo Breakdown of academic impact, for papers by Noriko Katori Breakdown of academic impact, for papers by Sandra Suarez‐Sharp Breakdown of academic impact, for papers by Shriram M. Pathak Breakdown of academic impact, for papers by Manuela Grimstein
Rankless by CCL
2026